Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference
Ultragenyx Pharmaceutical Inc. Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and...
Ultragenyx Pharmaceutical Inc. Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and...
Celltrion outlines a blueprint for innovative drug development built on its antibody expertise The company highlights its business strategy to...
As JPM Healthcare Week convenes industry leaders once again, the conversation feels markedly different than it did just twelve months...
On Jan. 4, 2023, GE HealthCare Technologies (No. 219 on the Fortune 500) debuted as a standalone public company on the Nasdaq exchange. Since then, its stock is up almost 50%. It was the...
The healthcare industry in the United States is rapidly transforming by adopting advanced technologies to improve patient care and navigate...
The multi-year study of healthcare professionals, conducted by NAHQ, shows a decisive shift from Quality as compliance to Quality as...
The post-pandemic era has ushered in a new paradigm of economic uncertainty, with healthcare inflation emerging as a defining challenge...
D&B Healthcare Insights, Available as an Add-On to D&B Hoovers, Elevates Sales & Marketing Strategies to Drive Commercial SuccessJACKSONVILLE, Fla.,...
Representational image. Credit: Canva Schneider Electric, a global leader in energy management and automation, has announced new progress in helping...